Product efficacy data submitted for publication

Our work developing the first generation of our novel breakthrough antimicrobials has been submitted for publication, showing that they target a range of Gram-positive and -negative bacteria with NO RESISTANCE.

Pre-publication the manuscript is available at https://www.biorxiv.org/content/10.1101/2022.09.02.506354v4